Works matching IS 15524949 AND DT 2023 AND VI 104 AND IP 6


Results: 10
    1
    2
    3

    Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry.

    Published in:
    Cytometry. Part B, 2023, v. 104, n. 6, p. 426, doi. 10.1002/cyto.b.22144
    By:
    • Tettero, Jesse M.;
    • Dakappagari, Naveen;
    • Heidinga, Maaike E.;
    • Oussoren‐Brockhoff, Yvonne;
    • Hanekamp, Diana;
    • Pahuja, Anil;
    • Burns, Kerri;
    • Kaur, Pavinder;
    • Alfonso, Zeni;
    • van der Velden, Vincent H. J.;
    • te Marvelde, Jeroen G.;
    • Hobo, Willemijn;
    • Slomp, Jennichjen;
    • Bachas, Costa;
    • Kelder, Angele;
    • Nguyen, Kevin;
    • Cloos, Jacqueline
    Publication type:
    Article
    4

    Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience.

    Published in:
    Cytometry. Part B, 2023, v. 104, n. 6, p. 440, doi. 10.1002/cyto.b.22139
    By:
    • Arunachalam, Arun Kumar;
    • Selvarajan, Sushil;
    • Mani, Thenmozhi;
    • Janet, Nancy Beryl;
    • Maddali, Madhavi;
    • Lionel, Sharon Anbumalar;
    • Kulkarni, Uday;
    • Korula, Anu;
    • Aboobacker, Fouzia N.;
    • Abraham, Aby;
    • George, Biju;
    • Balasubramanian, Poonkuzhali;
    • Mathews, Vikram
    Publication type:
    Article
    5
    6
    7
    8
    9
    10

    Issue Information.

    Published in:
    Cytometry. Part B, 2023, v. 104, n. 6, p. 407, doi. 10.1002/cyto.b.22078
    Publication type:
    Article